Close

Articles

Transforming the clinical data management process with Agile

Introduction The clinical research industry wants to achieve the common goal of accelerating drug development by improving the process of data collection, data validation, analysis, and submission. Faster time to market puts pressure on every aspect of trial including Clinical...

Biopharma 2022: 5 Trends Shaping the Industry

Just 10 months ago, pharma and biotech companies rode a wave of pandemic-driven innovation and historic funding levels into what many hoped would be another banner year. Now, after several quarters of shifting expectations, we can take stock: what...

How to plan cGMP-compliant clinical batches

For companies developing new injectable medications, manufacturing issues have become one of the greatest and most consistent early stumbling blocks. In fact, the FDA has issued more than 600 manufacturing citations in just the last five years. In the earliest...

The future of high-throughput screening

High-throughput screening (HTS) is a method for drug discovery that allows automated testing of large numbers of chemical and biological compounds for a specific biological target. Mass spectrometry is particularly appealing for HTS as it avoids a number of...

Converting Injectable Therapies to Combination Drug-Device Products

How to seize market opportunities while navigating the requirements of both drug therapies and delivery devices The global biopharma market has recently experienced a remarkable period of evolution and expansion. In that time, parenteral medications have become one of the...

Soft mist nasal sprays ready to take the sting out of vaccine delivery

The COVID-19 pandemic delivered many valuable lessons to the pharmaceutical industry, and emphasised the benefits of preparing for future pandemics. Wilbur de Kruijf at Recipharm argues how vaccines optimised for delivery by nasal administration devices using Soft Mist Inhaler...

Drug shortages and potential solutions to help mitigate them in the marketplace

Collaborative Solutions to Address Supply Chain Vulnerabilities and Mitigate Drug Shortages The challenges of the last several years have shined a light on the pharmaceutical supply chain, revealing both its incredible strengths and opportunities for enhancements. According to a recent...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read